Baltimore, MD (November 3, 2025) – RELI Group, a trusted partner to federal agencies in health and security, is proud to announce a strategic partnership with Basys.ai, a leading innovator in healthcare AI solutions. This collaboration underscores both organizations’ shared commitment to improving federal health programs, supporting government agencies in the safe and effective implementation of artificial intelligence, and combating fraud, waste and abuse.
“This partnership reflects our unwavering commitment to innovation with purpose,” said RELI’s founder and CEO, Mohammad Elias. “By joining forces with Basys.ai, we can equip federal agencies with tools that not only improve efficiency but also uphold the highest standards of integrity.”
Through this partnership, RELI and Basys.ai will combine deep domain expertise and cutting-edge technology to deliver solutions that enhance program integrity and operational efficiency. A key initiative under this alliance is SureReview, an AI-powered medical record review tool developed jointly by RELI and Basys.ai. SureReview is designed to streamline complex medical record audits, reduce administrative burden and improve accuracy in healthcare oversight. RELI plans to launch SureReview in 2026 as part of its broader mission to strengthen healthcare integrity across federal programs.
Following Mohammad’s vision for purposeful innovation, Basys.ai shares the same commitment to ethical and impactful AI. Amber Nigam, Co-Founder and CEO of Basys.ai, emphasized this alignment: “At Basys.ai, we believe in building AI that acts with purpose. Partnering with RELI Group allows us to bring our agentic AI capabilities to the federal space, where transparency and accountability are paramount. Together, we’re creating solutions like SureReview that empower agencies to make faster, smarter decisions while safeguarding patient data and public resources.”
As company leadership works together, the future is clear. “AI has immense potential to transform healthcare, but it must be implemented thoughtfully and ethically,” said RELI’s President & COO, Vishal Tulsian. “Our collaboration with Basys.ai ensures that technology serves the mission of protecting public trust, eliminating fraud, waste, and abuse, and delivering measurable value to the agencies we support.”
About RELI Group, Inc.
RELI Group is a mission-focused government consulting firm that serves as a trusted navigator for change across federal health and national security. We partner with government agencies to deliver innovative, outcome-driven solutions that improve public services and strengthen systems that protect the American people.
Our solutions span program integrity, digital transformation, intelligence and informatics, and operational efficiency, supported by deep expertise in cybersecurity; applied AI; mission delivery; data lifecycle management; and fraud, waste and abuse prevention.
We bring deep domain expertise, technical excellence and a clear focus on advancing the missions of our government partners. RELI Group is CMMI Level 3 appraised and ISO 9001, 20000 and 27001 certified, with a strong track record of supporting agencies such as CMS, NIH, TSA, DHS, FDA and more. To learn more, visit www.RELIgroupinc.com.
About Basys.ai
Basys.ai is a healthcare technology company dedicated to transforming clinical workflows through responsible artificial intelligence. Founded in 2022, Basys.ai specializes in automating complex processes such as prior authorization, utilization management, and medical record review. Its agentic AI platform is designed to improve efficiency, reduce administrative burden, and enhance transparency for healthcare organizations and government agencies. By combining cutting-edge technology with a commitment to ethical AI practices, Basys.ai empowers partners to deliver better outcomes while safeguarding patient data and public resources. Learn more at www.basys.ai.
